ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

NCT00003989 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC